JP2011529475A5 - - Google Patents

Download PDF

Info

Publication number
JP2011529475A5
JP2011529475A5 JP2011520506A JP2011520506A JP2011529475A5 JP 2011529475 A5 JP2011529475 A5 JP 2011529475A5 JP 2011520506 A JP2011520506 A JP 2011520506A JP 2011520506 A JP2011520506 A JP 2011520506A JP 2011529475 A5 JP2011529475 A5 JP 2011529475A5
Authority
JP
Japan
Prior art keywords
vaccine
vlp
dose
hpv
adjuvant
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2011520506A
Other languages
English (en)
Japanese (ja)
Other versions
JP2011529475A (ja
JP6022159B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2009/059820 external-priority patent/WO2010012780A1/en
Publication of JP2011529475A publication Critical patent/JP2011529475A/ja
Publication of JP2011529475A5 publication Critical patent/JP2011529475A5/ja
Application granted granted Critical
Publication of JP6022159B2 publication Critical patent/JP6022159B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2011520506A 2008-07-31 2009-07-29 抗ｈｐｖワクチン Active JP6022159B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US8510108P 2008-07-31 2008-07-31
US61/085,101 2008-07-31
US17656109P 2009-05-08 2009-05-08
US61/176,561 2009-05-08
PCT/EP2009/059820 WO2010012780A1 (en) 2008-07-31 2009-07-29 Vaccine against hpv

Publications (3)

Publication Number Publication Date
JP2011529475A JP2011529475A (ja) 2011-12-08
JP2011529475A5 true JP2011529475A5 (enExample) 2012-09-13
JP6022159B2 JP6022159B2 (ja) 2016-11-09

Family

ID=41139260

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2011520506A Active JP6022159B2 (ja) 2008-07-31 2009-07-29 抗ｈｐｖワクチン

Country Status (26)

Country Link
US (1) US20110189229A1 (enExample)
EP (1) EP2318042B1 (enExample)
JP (1) JP6022159B2 (enExample)
KR (1) KR20110053340A (enExample)
CN (1) CN102159239A (enExample)
AU (1) AU2009275909A1 (enExample)
BR (1) BRPI0916732B1 (enExample)
CA (1) CA2732436C (enExample)
CO (1) CO6341567A2 (enExample)
DK (1) DK2318042T3 (enExample)
DO (1) DOP2011000031A (enExample)
EA (1) EA201170264A1 (enExample)
ES (1) ES2519490T3 (enExample)
HR (1) HRP20141063T1 (enExample)
IL (1) IL210977A0 (enExample)
MA (1) MA32554B1 (enExample)
MX (1) MX2011001218A (enExample)
NZ (1) NZ590919A (enExample)
PE (1) PE20110327A1 (enExample)
PL (1) PL2318042T3 (enExample)
PT (1) PT2318042E (enExample)
RS (1) RS53607B1 (enExample)
SI (1) SI2318042T1 (enExample)
SM (1) SMT201400170B (enExample)
WO (1) WO2010012780A1 (enExample)
ZA (1) ZA201100889B (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2011013744A (es) 2009-06-25 2012-09-28 Glaxosmithkline Biolog Sa Construcciones novedosas de proteinas del virus de papiloma humano (hpv) y su uso en la prevencion de la enfermedad por el hpv.
CN102178944A (zh) * 2010-09-17 2011-09-14 大连雅立峰生物制药有限公司 人乳头瘤病毒16和18型l1蛋白在昆虫细胞中的表达及应用
CN102229660B (zh) 2011-05-25 2015-04-22 厦门大学 截短的人乳头瘤病毒33型l1蛋白
KR101559622B1 (ko) 2012-07-30 2015-10-13 중앙대학교 산학협력단 인유두종바이러스 바이러스 유사입자의 고효율 정제방법
CN107002085A (zh) * 2014-09-11 2017-08-01 卡迪拉保健有限公司 具有优异免疫学特性的优异的人乳头瘤病毒抗原和含有其的疫苗
US10063211B2 (en) 2016-02-03 2018-08-28 Qualcomm Incorporated Compact bypass and decoupling structure for millimeter-wave circuits
RU2628693C1 (ru) * 2016-11-10 2017-08-21 федеральное государственное бюджетное учреждение "Федеральный научно-исследовательский центр эпидемиологии и микробиологии имени почетного академика Н.Ф. Гамалеи" Министерства здравоохранения Российской Федерации (ФГБУ "ФНИЦЭМ им. Н.Ф. Гамалеи" Минздрава России) РЕКОМБИНАНТНЫЙ ГЕН L1HPV16, РЕКОМБИНАНТНАЯ ПЛАЗМИДА pQE-L1/16, БЕЛОК L1HPV16 И ИХ ПРИМЕНЕНИЕ
US20210302427A1 (en) * 2020-03-31 2021-09-30 Shuhari Group, LLC Secure Immunity Information Transmission System And Network
WO2025147639A1 (en) * 2024-01-04 2025-07-10 Cyanvac Llc Improved formulation providing increased stability for vaccines composition

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9921146D0 (en) * 1999-09-07 1999-11-10 Smithkline Beecham Biolog Novel composition
AU2005222776A1 (en) * 2003-12-31 2005-09-29 Genimmune N.V. Inducing cellular immune responses to human papillomavirus using peptide and nucleic acid compositions
MXPA06014515A (es) * 2004-06-16 2007-03-23 Glaxosmithkline Biolog Sa Vacuna contra vph16 y vph18 y al menos otro tipo de vph seleccionado de vph 31, 45 o 52.
US7758866B2 (en) * 2004-06-16 2010-07-20 Glaxosmithkline Biologicals, S.A. Vaccine against HPV16 and HPV18 and at least another HPV type selected from HPV 31, 45 or 52
KR20080005585A (ko) * 2005-04-26 2008-01-14 글락소스미스클라인 바이오로지칼즈 에스.에이. 백신

Similar Documents

Publication Publication Date Title
JP2011529475A5 (enExample)
US7709010B2 (en) Papillomavirus vaccine compositions
HRP20141063T1 (hr) Cjepivo protiv hpv
HRP20141258T1 (hr) 6-amino-2-{[(1s)-1-metilbutil]oksi}-9-[5-(1-piperidinil)pentil]-7,9-dihidro-8h-purin-8-on maleat
JP2011225578A5 (enExample)
JP2012517987A5 (ja) 吸入用の医薬組成物のｆｐｄ特性を設定する方法
JP2013519645A5 (enExample)
US11638754B2 (en) HPV vaccine
RU2017112308A (ru) Композиции и способы для лечения бессонницы
EP3216454B1 (en) Composition comprising polysaccharides extracted from lentinus, poria and tremella and use thereof for combating influenza virus
US20120045479A1 (en) Dry Powder Formulations, Vaccines and Methods
WO2024146068A1 (zh) 雷公藤红素或其可药用衍生物在制备疫苗佐剂中的用途
JP2013523682A5 (enExample)
CN105597092A (zh) 含有白介素15的防治hpv感染的疫苗喷雾剂
CN103599093B (zh) 一种抗hpv药物制剂及用途
TW202034950A (zh) 用於治療b型肝炎的藥物製劑及其製備方法和用途
RU2006143804A (ru) Вакцина против вирусов папилломы человека hpv16 и hpv18 и по меньшей мере еще одного типа hpv, выбранного из hpv 31,45 или 52
JP2011157395A5 (enExample)
US20230048144A1 (en) Hpv vaccine
WO2012097634A1 (zh) 一种治疗hpv感染的药物以及该药物在制备治疗hpv感染药物中的应用
JP4380967B2 (ja) ウイルス性心筋炎の予防または治療剤
CN105434631A (zh) 花椒精油在制备用于预防和/或治疗病毒性流感的药物或保健品中的应用
US20250205328A1 (en) Controlled release vaccine formulations
CN104208664A (zh) 一种鼻用疫苗组合物液体制剂及其制备方法
Somasundaram HPV vaccine: End to women's major health problem?